TUSCALOOSA, Alabama — February 8, 2009 (Business Wire)

MedSym, Inc. is pleased to announce it has been selected to participate in the American Society of Clinical Oncology's EHR Pilot Program to determine whether clinical decision support tools can be effectively utilized by oncologists through the incorporation of clinical guidelines tools into EHR products.

MedSym, Inc. (formerly ASCENT Integrated Medical Solutions) was one of ten EHR vendors selected to demonstrate ASCO's EHR Guidelines during the 2008 EHR Lab at ASCO's Annual Meeting. Following that event, Rabbit Healthcare Systems and MedSym, Inc. demonstrated interest and capabilities to take ASCO's Clinical Guideline Tools out of the lab and into a practice setting with existing oncology providers.

"Being recognized and selected by ASCO to participate in the Clinical Guideline Tools initiative for our work with oncology electronic medical records (EMR) technology from MedSym is a great opportunity to identify and expand the clinical value that technology can provide oncologists," says Keith Whitley, Senior Vice President for Southeast Cancer Network. "This program offers the potential to validate that tangible improvements can be made to the delivery of clinical decision support tools for oncologists through the application of technology. We look forward to learning from this project and further expanding our solutions to the treatment of cancer. We will continue to invest in technology solutions where they will have a real and positive impact on patient care. I wish to thank ASCO for identifying and supporting companies who, like ours, have made strategic decisions to harness the power of information technology to deliver the highest quality of service to physicians and patients."

Said Dr. Scott Drummond, founder and president of Southeast Cancer Network, "The team at MedSym commends ASCO for their ongoing commitment at operationalizing ASCO's oncology clinical guideline tools with the utilization of EMR technologies. By leveraging EMR's at the point-of-care, staff and physicians are able to make a wide range of high quality team-based care services accessible to their patients. As a wholly owned subsidiary of Southeast Cancer Network, MedSym will continue to maintain an expert focus on solutions that bring real value to oncologists and affiliated staff. We are very proud to see MedSym's efforts rewarded in such a prominent manner."

Both vendors will submit scheduled responses to specific usage, training, support, and content questions during the next 12 months. All responses will be confidential and ASCO, in its sole discretion, will determine whether or how to utilize the results. In this pilot ASCO hopes to find solutions to inconsistencies in clinical decision support functions by providing the same set of guideline support tools to vendors who have demonstrated they can incorporate these tools into their oncology solutions.
For more information about MedSym, Inc., please contact:

MedSym Inc.
Preston James, VP Sales & Marketing
1400 Afflink Place
Tuscaloosa, AL 35406
913-897-8102
pjames@medsyminc.com

About MedSym, Inc.

MedSym, Inc. (formerly ASCENT Integrated Medical Solutions) is a leading national provider of integrated practice management (PM) and electronic medical records (EMR) software for physician offices and medical clinics across the United States. Founded in 1995, MedSym's Oncology software, HemOncProEHR and HemOncProPM, includes a complete set of physician-designed applications that automate the unique processes of oncology billing, scheduling, workflow planning, chronic disease management and clinical practice for physician offices and medical clinics within the context of each physician's unique clinical processes. MedSym, Inc. is a wholly owned subsidiary of Southeast Cancer Network. Southeast Cancer Network is a 14-site cancer care organization with over three hundred dedicated associates delivering patient care services spanning the southern United States. For more information on MedSym, Inc., visit www.medsyminc.com.

About ASCO

The American Society of Clinical Oncology (ASCO) is the world's leading professional organization representing physicians who care for people with cancer. With more than 27,000 members, ASCO is committed to improving cancer care through scientific meetings, educational programs and peer-reviewed journals. For ASCO information and resources, visit www.asco.org/presscenter/. Patient-oriented cancer information is available at www.cancer.net.

SOURCE: MedSym, Inc.

###